Citations for
1ALB, FDAH
A novel albumin gene mutation (R222I) in familial dysalbuminemic hyperthyroxinemia.
Schoenmakers N, Moran C, Campi I, Agostini M, Bacon O, Rajanayagam O, Schwabe J, Bradbury S, Barrett T, Geoghegan F, Druce M, Beck-Peccoz P, O'Toole A, Clark P, Bignell M, Lyons G, Halsall D, Gurnell M, Chatterjee K.
J Clin Endocrinol Metab 99(7):E1381-6. doi: 10.1210/jc.2013-4077. Epub 2014 Mar 19. Erratum in: J Clin Endocrinol Metab. 2015 Apr;100(4):1709. 2014
2ALB, FDAH
A novel missense mutation in codon 218 of the albumin gene in a distinct phenotype of familial dysalbuminemic hyperthyroxinemia in a Japanese kindred.
Wada N, Chiba H, Shimizu C, Kijima H, Kubo M, Koike T.
J Clin Endocrinol Metab 82(10):3246-50. 1997
3ALB, FDAH
Mutations in a specific human serum albumin thyroxine binding site define the structural basis of familial dysalbuminemic hyperthyroxinemia.
Petersen CE, et al.
J Biol Chem 271 : 19110-19117. 1996
4FDAH
Linkage of familial dysalbuminemic hyperthyroxinemia to the albumin gene in a large Amish kindred.
Weiss RE, et al.
J Clin Endocrinol Metab 80 : 116-121. 1995
5ALB, FDAH
A point mutation in the human serum albumin gene results in familial dysalbuminaemic hyperthyroxinaemia.
Petersen CE, et al.
J Med Genet 31 : 355-359. 1994
6ALB, FDAH
Hyperthyroxinemia due to the coexistence of two raised affinity thyroxine-binding proteins (albumin and prealbumin) in one family.
Lalloz MRA, et al.
J Clin Endocrinol Metab 64 : 346-352. 1987